Pages

Thursday, 30 October 2014

US earnings catch-up...CME Group

CME Group is not an easy company to appraise.  I called it expensive three months ago (link here) and maintained my short position but that was a mistake and the stock never did break below the US$70 cover level I mooted back then:


So what to think now?  Well the headlines sounded pretty good. This from Seeking Alpha:

'Q3 adjusted net income of $280.8M or $0.84 per share compares to net income of $236.7M and $0.71 one year ago.  Average daily volume of 13.5M contracts up 12% Y/Y. Clearing and transaction fee revenues of $641.8M up 7%. Total average rate per contract of $0.725 down from $0.749 as the highest growth came from lower-priced contracts. Adjusted operating expenses for full-year 2014 are expected to be about $1.3B - the low end of the previously stated range. 2015 should be about $1.3B as well'

Certainly it looks as if the 'slight volatility uptick' noted in the results had a positive impact...

...and international (i.e. non US) contracts growth accounted for 60% of the quarter's volume expansion which is a very good effort.

Two other aspects of the results caught my attention as well.  The first was the continuing commitment to the c. 5% of market cap return to shareholders assisted by the 'annual variable dividend'.

And then there was the good start to October noted in the results presentation too...always good to have that tucked away for the Q4 results...

So the only aspect not to like is the rating which is probably still prospectively in the x16s EV/ebit.  This is the only aspect that keeps me even remotely interested in a short position, that the enthusiasm is a little too high currently.  Currently one to watch out for if there are a few red days in unison.  Grudgingly I was impressed.  

No comments:

Post a Comment